Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma

Bibliographic Details
Main Authors:	Erlich, R B, Kherrouche, Z, Rickwood, D, Endo-Munoz, L, Cameron, S, Dahler, A, Hazar-Rethinam, M, de Long, L M, Wooley, K, Guminski, A, Saunders, N A
Format:	Online
Language:	English
Published:	Nature Publishing Group 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251846/

id	pubmed-3251846
recordtype	oai_dc
spelling	pubmed-32518462013-01-03 Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma Erlich, R B Kherrouche, Z Rickwood, D Endo-Munoz, L Cameron, S Dahler, A Hazar-Rethinam, M de Long, L M Wooley, K Guminski, A Saunders, N A Translational Therapeutics Nature Publishing Group 2012-01-03 2011-11-24 /pmc/articles/PMC3251846/ /pubmed/22116303 http://dx.doi.org/10.1038/bjc.2011.495 Text en Copyright © 2012 Cancer Research UK
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Erlich, R B Kherrouche, Z Rickwood, D Endo-Munoz, L Cameron, S Dahler, A Hazar-Rethinam, M de Long, L M Wooley, K Guminski, A Saunders, N A
spellingShingle	Erlich, R B Kherrouche, Z Rickwood, D Endo-Munoz, L Cameron, S Dahler, A Hazar-Rethinam, M de Long, L M Wooley, K Guminski, A Saunders, N A Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma
author_facet	Erlich, R B Kherrouche, Z Rickwood, D Endo-Munoz, L Cameron, S Dahler, A Hazar-Rethinam, M de Long, L M Wooley, K Guminski, A Saunders, N A
author_sort	Erlich, R B
title	Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma
title_short	Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma
title_full	Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma
title_fullStr	Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma
title_full_unstemmed	Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma
title_sort	preclinical evaluation of dual pi3k-mtor inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma
description
publisher	Nature Publishing Group
publishDate	2012
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251846/
_version_	1611498205030121472

Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma

Similar Items